Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$5.65 -0.04 (-0.70%)
2/9/2010 4:00 PM

Cardionet (BEAT)

CAPS Rating:
***

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating BEAT

Add Stock to Watchlist

What the Community Thinks

Total Members

185 Outperforms
27 Underperforms
 

All-Stars

78 Outperforms
7 Underperforms
 

Wall Street

4 Outperforms
2 Underperforms
 

Members bullish on BEAT are also bullish on:

Members bearish on BEAT are also bearish on:

Ticker Tags

Healthcare Providers and Services (125), IPO in 2008 (40), Healthcare (711), Micro Cap (4701), Defensive (1457), Value (1901)
Suggest a tag

Cardionet At A Glance

Current Price: $5.65
Last Trade Time: 2/9/2010 4:00 PM
Open: $5.61
Previous Close: $5.69
Daily Range: $5.57 - $5.76
52-Week Range: $4.22 - $29.50
Volume: 162,722
Market Cap: $134.86M
P/E Ratio: 29.95
Compare Our Special Broker Offers!

Stock Trends

BEAT VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

2

Cardionet (BEAT)

Avatar CBombay (30.06) Submitted: 10/09/09 1:15 PM

Teen Beat is a great magazine. They guys should do well for as long as there are teenagers.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Cardionet (BEAT)

Avatar pong2015 (65.47) Submitted: 4/17/09 1:48 AM

Output from Asterism:
20/17
20/18
=> -1

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 29 :   1 2 3 4 5 Next »

Recs

0

 (BEAT)

Avatar TSIF (98.89) Submitted: 12/15/09 6:55 PM : Outperform Start Price: $5.85 BEAT Score: 0.53

Cardionet, (with it's approptiate "ticker") has had a volitile year. With a peak of $27.00 and a low of $4.22 one would think that Cardionet was a typical recesson bound company with too much debt or a biopharm that went bad. Anyone watching it's heart beat on a monitor might have sent in a life support team. In reality, Cardionet is suffering from reduced medicare repayment rates on their mobile heart monitoring devices. Add the fear that the governement will hammer them more and you have the makings for little reason to take risk. Cardionet's products, however are necessary and while margins may be thin, overall they are profitable and the company could be attractive as mergers and acquistions come about. Cardionet has had an incease in patients and without the 33% trim from Medicare would probably be one of this years winners. Cash on hand is strong and debt pretty much nonexistant. I believe that Cardionet will find a way to grow, either organically or in one fell swoop with a decent premium from a buyout.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BEAT)

Avatar thesaneinvestor (38.58) Submitted: 12/15/09 5:00 PM : Outperform Start Price: $6.20 BEAT Score: -4.77

This is a value play.

I'll start with the pluses:
- Strong product
- Health sector play
- 1.34 P/B when you take out goodwill and intangibles, and a majority of this is cash and cash equivalents
- To bring stock up to a P/B of 1, goodwill can withstand a 23.6% markdown
- Company outlined plans in their 10-Q to try and reduce the SG&A and COGS for their products, which hopefully could bring their cash flows from operations in to the black
- Large cash reserves give this company time to get their stuff straight

And the minuses:
- Company would have had to reduce COGS and SG&A by 22% in the most recent quarter to report an operating income of 0.
- Plans outlined in the most recent 10-Q may not be able to accomplish the necessary dramatic reductions in operating expenses.

My hope is that either a lower Revenue/SG&A due to growth or cost cutting will hopefully make them profitable, and they'll do it fast enough for the market to re-evaluate the value of this stock (i.e. without complete toasting all of their cash reserves). They've got some space to breath to turn this around as well. This is definitely a riskier bet.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BEAT)

Avatar brew8160 (< 20) Submitted: 12/15/09 10:05 AM : Outperform Start Price: $5.78 BEAT Score: 1.57

Cost cutting, outsourcing, aggresive growth (45%) over last year. Good hires for strategic measures.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BEAT)

Avatar Clint35 (60.02) Submitted: 12/12/09 5:56 AM : Underperform Start Price: $4.99 BEAT Score: -17.38

Their gross margins are real good. But their other margins are paper thin. Which indicates they're not running the business very well. For such a small company insider ownership is very low. The P/E is too high considering sales growth YOY is below 10%.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BEAT)

Avatar spreadsheetV1 (94.05) Submitted: 11/23/09 1:27 AM : Outperform Start Price: $5.12 BEAT Score: 13.51

This met a high level screen to indicate a buy and strong outperform against its peers (other tickers in its industry). My 1st version of this spreadsheet devles deep into the company's balnace sheet and recent income statements, combined with other relevant price data for the company including insider/institutional holdings, short interest, debt levels, etc.
Testing capabilities of this 1st version of my automated, valuation spreadhseet matched with my personal criteria and see how it holds up.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 29 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 6 of 6  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackLeerinkSwan 92.83 12/16/09 Outperform NS $6.20-8.87%-4.10%-4.77
TrackJimCramer < 20 05/26/09 Underperform 3W $18.76-69.88%+18.66%+88.54
TrackJefferies 82.08 04/24/09 Underperform NS $21.10-73.22%+25.94%+99.16
TrackStanfordRes 85.54 09/19/08 Outperform NS $27.10-79.15%-13.55%-65.60
TrackCowenandCo 86.76 09/05/08 Outperform NS $29.82-81.05%-10.31%-70.74

Results 1 - 6 of 6  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD01 281ms